The Plastic Surgery Foundation
Log In Donate Now
 

Grants We Funded

Grant applicants for the 2022 cycle requested a total of over $2.9 million dollars. The PSF Study Section subcommittees of Basic & Translational Research and Clinical Research evaluated 115 grant applications on the following topics:

The PSF awarded research grants totaling almost $550,000 to support 19 plastic surgery research proposals.

ASPS/PSF leadership is committed to continuing to provide high levels of investigator-initiated research support to ensure that plastic surgeons have the needed research resources to be pioneers and innovators in advancing the practice of medicine.

Research Abstracts

Search The PSF database to have easy access to full-text grant abstracts from past PSF-funded research projects 2003 to present. All abstracts are the work of the Principal Investigators and were retrieved from their PSF grant applications. Several different filters may be applied to locate abstracts specific to a particular focus area or PSF funding mechanism.

Human Adipose Derived Adult Stem Cells as an Engineered Bone Substitute for Segmental Osseous Defects

Kurtis Moyer MD · Duke University

Human and Mouse Osteoblasts Exhibit Distinct Patterns of Osteogenesis in 3D

Clifford Pereira MD · VA Medical Center West Los Angeles

Human Muscle Progenitor and Regeneration

Eric Chien-Wei Liao MD, PhD · Massachusetts General Hospital (The General Hospital Corp.)

Hydrogen sulfide as pre-and post-ischemic cytoprotectant in vivo

Jason Spector MD · Joan & Sanford I. Weill Medical College of Cornell University

Identification of Regenerative and Scarring Fibroblasts in the Orofacial Region

Michelle Griffin PhD · Stanford University School of Medicine

Identification of the Human Cutaneous Fibroblast Stem Cell

Mimi Borrelli MD · Stanford University

IGF-1 Nanoparticles to Improve Functional Recovery after Peripheral Nerve Injury

Philip Hanwright MD · Johns Hopkins University-School of Medicine

IGFR1: A Potential Therapeutic Target For Dupuytren's Disease

Bing Siang Gan MD · Lawson Health Research Institute (Lawson)

IL-2 immunomodulation and topical immunosuppression in CTA

Rishi Jindal MD · University of Pittsburgh

Immune Cell Specific Therapy to Prevent Extremity Heterotopic Ossification

David Stepien MD, PhD · The Regents of the University of Michigan